Izokibep for the treatment of moderate-to-severe plaque psoriasis: a phase II, randomized, placebo-controlled, double-blind, dose-finding multicentre study including long-term treatment.

Sascha Gerdes,Petra Staubach, Thomas Dirschka, Dieter Wetzel, Oliver Weirich, Johannes Niesmann, Rodrigo da Mota, Alex Rothhaar, Michael Ardabili, Gerda Vlasitz,Joachim Feldwisch,Lisa Osterling Koskinen,Sven Ohlman,Paul M Peloso,Nikolai C Brun,Fredrik Y Frejd

The British journal of dermatology（2023）

引用 0|浏览13

暂无评分

摘要

Data from this phase II study indicate that izokibep is well tolerated and efficacious in the treatment of plaque psoriasis. Higher doses or more frequent dosing could be explored to further enhance response rates.

查看译文

关键词

psoriasis,treatment,moderate-to-severe,placebo-controlled,double-blind,dose-finding,long-term

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要